[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Critical Care Diagnostics - Global Market Outlook (2017-2023)

October 2017 | 178 pages | ID: CF59A199E48EN
Stratistics Market Research Consulting

US$ 4,150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to Stratistics MRC, the Global Critical Care Diagnostics market is accounted for $0.86 billion in 2016 and is expected to reach $1.34 billion by 2023 growing at a CAGR of 6.5% from 2016 to 2023. Growing aging population and chronic health concerns, improving advancements in technologies and rapid attentiveness, increasing acceptance of these tests by physicians and patients are some of factors triggering the market growth. Furthermore, growing incidence of chronic disease such as cancer, heart disease, and diabetes are fuelling the market growth.

However, increased price of the molecular diagnostics and shortage of skilled professionals are some of the factors restraining the market growth.

Microbial and Infectious diseases test segment is anticipated to grow at the highest CAGR during the forecast period. The growth is owing to the quick and accurate test results to diagnose the disease. Immunoproteins diagnostic test segment accounted for largest market revenue due to increase massive demand for early disease diagnosis. North America represents as the largest market in terms of revenue. High research and development activities, higher demand from U.S boosting the North America market. Asia Pacific is projected to dominate the global market in terms of revenue due to rising specialty hospitals and convalescing healthcare services and infrastructures in rural areas.

Some of the key players profiled in this market include Abbott Laboratories, Alere, Inc., Bayer Healthcare AG, Beckman Coulter, Becton Dickinson & Co., BioMerieux, Inc., Bio-Rad Laboratories, Biosensors Japan, Chembio Diagnostic Systems, Inc., EKF Diagnostics, Nanomix Inx., Nova Biomedical, Roche Diagnostics Ltd., Siemens Healthcare Diagnostics, and Sysmex Corporation.

Product Types Covered:
  • Cancer markers testing kit
  • Cardiometabolic monitoring kits
  • Fecal Occult testing kits
  • Drugs-Of-Abuse testing kits
  • Coagulation monitoring kits
  • Cholesterol test strips
  • Glucose monitoring kits
  • Pregnancy and fertility testing kits
  • Infectious Disease testing kits
  • Hematology testing kits
  • Other critical care diagnostics testing kits
Test Types Covered:
  • Hematology
  • Coagulation
  • Routine & Special Chemistry
  • Microbial & Infectious Test
  • Flow Cytometry
  • Immunoproteins
  • Other Test Types
Prescription Modes Covered:
  • OTC Testing Kits
  • Prescription-Based Testing Kits
End Users Covered:
  • Ambulatory surgical centers
  • Home
  • Hospitals
  • Research Laboratories
Regions Covered:
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
What our report offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE

5.1 Introduction
5.2 Cancer markers testing kit
5.3 Cardiometabolic monitoring kits
5.4 Fecal Occult testing kits
5.5 Drugs-Of-Abuse testing kits
5.6 Coagulation monitoring kits
5.7 Cholesterol test strips
5.8 Glucose monitoring kits
5.9 Pregnancy and fertility testing kits
5.10 Infectious Disease testing kits
5.11 Hematology testing kits
5.12 Other critical care diagnostics testing kits

6 GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, BY TEST TYPE

6.1 Introduction
6.2 Hematology
6.3 Coagulation
6.4 Routine & Special Chemistry
6.5 Microbial & Infectious Test
6.6 Flow Cytometry
6.7 Immunoproteins
6.8 Other Test Types

7 GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, BY PRESCRIPTION MODE

7.1 Introduction
7.2 OTC Testing Kits
7.3 Prescription-Based Testing Kits

8 GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, BY END USER

8.1 Introduction
8.2 Ambulatory surgical centers
8.3 Home
8.4 Hospitals
8.5 Research Laboratories

9 GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, BY GEOGRAPHY

9.1 Introduction
9.2 North America
  9.2.1 US
  9.2.2 Canada
  9.2.3 Mexico
9.3 Europe
  9.3.1 Germany
  9.3.2 UK
  9.3.3 Italy
  9.3.4 France
  9.3.5 Spain
  9.3.6 Rest of Europe
9.4 Asia Pacific
  9.4.1 Japan
  9.4.2 China
  9.4.3 India
  9.4.4 Australia
  9.4.5 New Zealand
  9.4.6 South Korea
  9.4.7 Rest of Asia Pacific
9.5 South America
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America
9.6 Middle East & Africa
  9.6.1 Saudi Arabia
  9.6.2 UAE
  9.6.3 Qatar
  9.6.4 South Africa
  9.6.5 Rest of Middle East & Africa

10 KEY DEVELOPMENTS

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 COMPANY PROFILING

11.1 Abbott Laboratories
11.2 Alere, Inc.
11.3 Bayer Healthcare AG
11.4 Beckman Coulter
11.5 Becton Dickinson & Co.
11.6 BioMerieux, Inc.
11.7 Bio-Rad Laboratories
11.8 Biosensors Japan
11.9 Chembio Diagnostic Systems, Inc.
11.10 EKF Diagnostics
11.11 Nanomix Inx.
11.12 Nova Biomedical
11.13 Roche Diagnostics Ltd.
11.14 Siemens Healthcare Diagnostics
11.15 Sysmex Corporation

LIST OF TABLES

Table 1 Global Critical Care Diagnostics Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Critical Care Diagnostics Market Outlook, By Product Type (2014-2023) ($MN)
Table 3 Global Critical Care Diagnostics Market Outlook, By Cancer markers testing kit (2014-2023) ($MN)
Table 4 Global Critical Care Diagnostics Market Outlook, By Cardiometabolic monitoring kits (2014-2023) ($MN)
Table 5 Global Critical Care Diagnostics Market Outlook, By Fecal Occult testing kits (2014-2023) ($MN)
Table 6 Global Critical Care Diagnostics Market Outlook, By Drugs-Of-Abuse testing kits (2014-2023) ($MN)
Table 7 Global Critical Care Diagnostics Market Outlook, By Coagulation monitoring kits (2014-2023) ($MN)
Table 8 Global Critical Care Diagnostics Market Outlook, By Cholesterol test strips (2014-2023) ($MN)
Table 9 Global Critical Care Diagnostics Market Outlook, By Glucose monitoring kits (2014-2023) ($MN)
Table 10 Global Critical Care Diagnostics Market Outlook, By Pregnancy and fertility testing kits (2014-2023) ($MN)
Table 11 Global Critical Care Diagnostics Market Outlook, By Infectious Disease testing kits (2014-2023) ($MN)
Table 12 Global Critical Care Diagnostics Market Outlook, By Hematology testing kits (2014-2023) ($MN)
Table 13 Global Critical Care Diagnostics Market Outlook, By Other critical care diagnostics testing kits (2014-2023) ($MN)
Table 14 Global Critical Care Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 15 Global Critical Care Diagnostics Market Outlook, By Hematology (2014-2023) ($MN)
Table 16 Global Critical Care Diagnostics Market Outlook, By Coagulation (2014-2023) ($MN)
Table 17 Global Critical Care Diagnostics Market Outlook, By Routine & Special Chemistry (2014-2023) ($MN)
Table 18 Global Critical Care Diagnostics Market Outlook, By Microbial & Infectious Test (2014-2023) ($MN)
Table 19 Global Critical Care Diagnostics Market Outlook, By Flow Cytometry (2014-2023) ($MN)
Table 20 Global Critical Care Diagnostics Market Outlook, By Immunoproteins (2014-2023) ($MN)
Table 21 Global Critical Care Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 22 Global Critical Care Diagnostics Market Outlook, By Prescription Mode (2014-2023) ($MN)
Table 23 Global Critical Care Diagnostics Market Outlook, By OTC Testing Kits (2014-2023) ($MN)
Table 24 Global Critical Care Diagnostics Market Outlook, By Prescription-Based Testing Kits (2014-2023) ($MN)
Table 25 Global Critical Care Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 26 Global Critical Care Diagnostics Market Outlook, By Ambulatory surgical centers (2014-2023) ($MN)
Table 27 Global Critical Care Diagnostics Market Outlook, By Home (2014-2023) ($MN)
Table 28 Global Critical Care Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 29 Global Critical Care Diagnostics Market Outlook, By Research Laboratories (2014-2023) ($MN)
Table 30 North America Critical Care Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 31 North America Critical Care Diagnostics Market Outlook, By Product Type (2014-2023) ($MN)
Table 32 North America Critical Care Diagnostics Market Outlook, By Cancer markers testing kit (2014-2023) ($MN)
Table 33 North America Critical Care Diagnostics Market Outlook, By Cardiometabolic monitoring kits (2014-2023) ($MN)
Table 34 North America Critical Care Diagnostics Market Outlook, By Fecal Occult testing kits (2014-2023) ($MN)
Table 35 North America Critical Care Diagnostics Market Outlook, By Drugs-Of-Abuse testing kits (2014-2023) ($MN)
Table 36 North America Critical Care Diagnostics Market Outlook, By Coagulation monitoring kits (2014-2023) ($MN)
Table 37 North America Critical Care Diagnostics Market Outlook, By Cholesterol test strips (2014-2023) ($MN)
Table 38 North America Critical Care Diagnostics Market Outlook, By Glucose monitoring kits (2014-2023) ($MN)
Table 39 North America Critical Care Diagnostics Market Outlook, By Pregnancy and fertility testing kits (2014-2023) ($MN)
Table 40 North America Critical Care Diagnostics Market Outlook, By Infectious Disease testing kits (2014-2023) ($MN)
Table 41 North America Critical Care Diagnostics Market Outlook, By Hematology testing kits (2014-2023) ($MN)
Table 42 North America Critical Care Diagnostics Market Outlook, By Other critical care diagnostics testing kits (2014-2023) ($MN)
Table 43 North America Critical Care Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 44 North America Critical Care Diagnostics Market Outlook, By Hematology (2014-2023) ($MN)
Table 45 North America Critical Care Diagnostics Market Outlook, By Coagulation (2014-2023) ($MN)
Table 46 North America Critical Care Diagnostics Market Outlook, By Routine & Special Chemistry (2014-2023) ($MN)
Table 47 North America Critical Care Diagnostics Market Outlook, By Microbial & Infectious Test (2014-2023) ($MN)
Table 48 North America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2014-2023) ($MN)
Table 49 North America Critical Care Diagnostics Market Outlook, By Immunoproteins (2014-2023) ($MN)
Table 50 North America Critical Care Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 51 North America Critical Care Diagnostics Market Outlook, By Prescription Mode (2014-2023) ($MN)
Table 52 North America Critical Care Diagnostics Market Outlook, By OTC Testing Kits (2014-2023) ($MN)
Table 53 North America Critical Care Diagnostics Market Outlook, By Prescription-Based Testing Kits (2014-2023) ($MN)
Table 54 North America Critical Care Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 55 North America Critical Care Diagnostics Market Outlook, By Ambulatory surgical centers (2014-2023) ($MN)
Table 56 North America Critical Care Diagnostics Market Outlook, By Home (2014-2023) ($MN)
Table 57 North America Critical Care Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 58 North America Critical Care Diagnostics Market Outlook, By Research Laboratories (2014-2023) ($MN)
Table 59 Europe Critical Care Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 60 Europe Critical Care Diagnostics Market Outlook, By Product Type (2014-2023) ($MN)
Table 61 Europe Critical Care Diagnostics Market Outlook, By Cancer markers testing kit (2014-2023) ($MN)
Table 62 Europe Critical Care Diagnostics Market Outlook, By Cardiometabolic monitoring kits (2014-2023) ($MN)
Table 63 Europe Critical Care Diagnostics Market Outlook, By Fecal Occult testing kits (2014-2023) ($MN)
Table 64 Europe Critical Care Diagnostics Market Outlook, By Drugs-Of-Abuse testing kits (2014-2023) ($MN)
Table 65 Europe Critical Care Diagnostics Market Outlook, By Coagulation monitoring kits (2014-2023) ($MN)
Table 66 Europe Critical Care Diagnostics Market Outlook, By Cholesterol test strips (2014-2023) ($MN)
Table 67 Europe Critical Care Diagnostics Market Outlook, By Glucose monitoring kits (2014-2023) ($MN)
Table 68 Europe Critical Care Diagnostics Market Outlook, By Pregnancy and fertility testing kits (2014-2023) ($MN)
Table 69 Europe Critical Care Diagnostics Market Outlook, By Infectious Disease testing kits (2014-2023) ($MN)
Table 70 Europe Critical Care Diagnostics Market Outlook, By Hematology testing kits (2014-2023) ($MN)
Table 71 Europe Critical Care Diagnostics Market Outlook, By Other critical care diagnostics testing kits (2014-2023) ($MN)
Table 72 Europe Critical Care Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 73 Europe Critical Care Diagnostics Market Outlook, By Hematology (2014-2023) ($MN)
Table 74 Europe Critical Care Diagnostics Market Outlook, By Coagulation (2014-2023) ($MN)
Table 75 Europe Critical Care Diagnostics Market Outlook, By Routine & Special Chemistry (2014-2023) ($MN)
Table 76 Europe Critical Care Diagnostics Market Outlook, By Microbial & Infectious Test (2014-2023) ($MN)
Table 77 Europe Critical Care Diagnostics Market Outlook, By Flow Cytometry (2014-2023) ($MN)
Table 78 Europe Critical Care Diagnostics Market Outlook, By Immunoproteins (2014-2023) ($MN)
Table 79 Europe Critical Care Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 80 Europe Critical Care Diagnostics Market Outlook, By Prescription Mode (2014-2023) ($MN)
Table 81 Europe Critical Care Diagnostics Market Outlook, By OTC Testing Kits (2014-2023) ($MN)
Table 82 Europe Critical Care Diagnostics Market Outlook, By Prescription-Based Testing Kits (2014-2023) ($MN)
Table 83 Europe Critical Care Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 84 Europe Critical Care Diagnostics Market Outlook, By Ambulatory surgical centers (2014-2023) ($MN)
Table 85 Europe Critical Care Diagnostics Market Outlook, By Home (2014-2023) ($MN)
Table 86 Europe Critical Care Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 87 Europe Critical Care Diagnostics Market Outlook, By Research Laboratories (2014-2023) ($MN)
Table 88 Asia Pacific Critical Care Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 89 Asia Pacific Critical Care Diagnostics Market Outlook, By Product Type (2014-2023) ($MN)
Table 90 Asia Pacific Critical Care Diagnostics Market Outlook, By Cancer markers testing kit (2014-2023) ($MN)
Table 91 Asia Pacific Critical Care Diagnostics Market Outlook, By Cardiometabolic monitoring kits (2014-2023) ($MN)
Table 92 Asia Pacific Critical Care Diagnostics Market Outlook, By Fecal Occult testing kits (2014-2023) ($MN)
Table 93 Asia Pacific Critical Care Diagnostics Market Outlook, By Drugs-Of-Abuse testing kits (2014-2023) ($MN)
Table 94 Asia Pacific Critical Care Diagnostics Market Outlook, By Coagulation monitoring kits (2014-2023) ($MN)
Table 95 Asia Pacific Critical Care Diagnostics Market Outlook, By Cholesterol test strips (2014-2023) ($MN)
Table 96 Asia Pacific Critical Care Diagnostics Market Outlook, By Glucose monitoring kits (2014-2023) ($MN)
Table 97 Asia Pacific Critical Care Diagnostics Market Outlook, By Pregnancy and fertility testing kits (2014-2023) ($MN)
Table 98 Asia Pacific Critical Care Diagnostics Market Outlook, By Infectious Disease testing kits (2014-2023) ($MN)
Table 99 Asia Pacific Critical Care Diagnostics Market Outlook, By Hematology testing kits (2014-2023) ($MN)
Table 100 Asia Pacific Critical Care Diagnostics Market Outlook, By Other critical care diagnostics testing kits (2014-2023) ($MN)
Table 101 Asia Pacific Critical Care Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 102 Asia Pacific Critical Care Diagnostics Market Outlook, By Hematology (2014-2023) ($MN)
Table 103 Asia Pacific Critical Care Diagnostics Market Outlook, By Coagulation (2014-2023) ($MN)
Table 104 Asia Pacific Critical Care Diagnostics Market Outlook, By Routine & Special Chemistry (2014-2023) ($MN)
Table 105 Asia Pacific Critical Care Diagnostics Market Outlook, By Microbial & Infectious Test (2014-2023) ($MN)
Table 106 Asia Pacific Critical Care Diagnostics Market Outlook, By Flow Cytometry (2014-2023) ($MN)
Table 107 Asia Pacific Critical Care Diagnostics Market Outlook, By Immunoproteins (2014-2023) ($MN)
Table 108 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 109 Asia Pacific Critical Care Diagnostics Market Outlook, By Prescription Mode (2014-2023) ($MN)
Table 110 Asia Pacific Critical Care Diagnostics Market Outlook, By OTC Testing Kits (2014-2023) ($MN)
Table 111 Asia Pacific Critical Care Diagnostics Market Outlook, By Prescription-Based Testing Kits (2014-2023) ($MN)
Table 112 Asia Pacific Critical Care Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 113 Asia Pacific Critical Care Diagnostics Market Outlook, By Ambulatory surgical centers (2014-2023) ($MN)
Table 114 Asia Pacific Critical Care Diagnostics Market Outlook, By Home (2014-2023) ($MN)
Table 115 Asia Pacific Critical Care Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 116 Asia Pacific Critical Care Diagnostics Market Outlook, By Research Laboratories (2014-2023) ($MN)
Table 117 South America Critical Care Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 118 South America Critical Care Diagnostics Market Outlook, By Product Type (2014-2023) ($MN)
Table 119 South America Critical Care Diagnostics Market Outlook, By Cancer markers testing kit (2014-2023) ($MN)
Table 120 South America Critical Care Diagnostics Market Outlook, By Cardiometabolic monitoring kits (2014-2023) ($MN)
Table 121 South America Critical Care Diagnostics Market Outlook, By Fecal Occult testing kits (2014-2023) ($MN)
Table 122 South America Critical Care Diagnostics Market Outlook, By Drugs-Of-Abuse testing kits (2014-2023) ($MN)
Table 123 South America Critical Care Diagnostics Market Outlook, By Coagulation monitoring kits (2014-2023) ($MN)
Table 124 South America Critical Care Diagnostics Market Outlook, By Cholesterol test strips (2014-2023) ($MN)
Table 125 South America Critical Care Diagnostics Market Outlook, By Glucose monitoring kits (2014-2023) ($MN)
Table 126 South America Critical Care Diagnostics Market Outlook, By Pregnancy and fertility testing kits (2014-2023) ($MN)
Table 127 South America Critical Care Diagnostics Market Outlook, By Infectious Disease testing kits (2014-2023) ($MN)
Table 128 South America Critical Care Diagnostics Market Outlook, By Hematology testing kits (2014-2023) ($MN)
Table 129 South America Critical Care Diagnostics Market Outlook, By Other critical care diagnostics testing kits (2014-2023) ($MN)
Table 130 South America Critical Care Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 131 South America Critical Care Diagnostics Market Outlook, By Hematology (2014-2023) ($MN)
Table 132 South America Critical Care Diagnostics Market Outlook, By Coagulation (2014-2023) ($MN)
Table 133 South America Critical Care Diagnostics Market Outlook, By Routine & Special Chemistry (2014-2023) ($MN)
Table 134 South America Critical Care Diagnostics Market Outlook, By Microbial & Infectious Test (2014-2023) ($MN)
Table 135 South America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2014-2023) ($MN)
Table 136 South America Critical Care Diagnostics Market Outlook, By Immunoproteins (2014-2023) ($MN)
Table 137 South America Critical Care Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 138 South America Critical Care Diagnostics Market Outlook, By Prescription Mode (2014-2023) ($MN)
Table 139 South America Critical Care Diagnostics Market Outlook, By OTC Testing Kits (2014-2023) ($MN)
Table 140 South America Critical Care Diagnostics Market Outlook, By Prescription-Based Testing Kits (2014-2023) ($MN)
Table 141 South America Critical Care Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 142 South America Critical Care Diagnostics Market Outlook, By Ambulatory surgical centers (2014-2023) ($MN)
Table 143 South America Critical Care Diagnostics Market Outlook, By Home (2014-2023) ($MN)
Table 144 South America Critical Care Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 145 South America Critical Care Diagnostics Market Outlook, By Research Laboratories (2014-2023) ($MN)
Table 146 Middle East & Africa Critical Care Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 147 Middle East & Africa Critical Care Diagnostics Market Outlook, By Product Type (2014-2023) ($MN)
Table 148 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cancer markers testing kit (2014-2023) ($MN)
Table 149 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cardiometabolic monitoring kits (2014-2023) ($MN)
Table 150 Middle East & Africa Critical Care Diagnostics Market Outlook, By Fecal Occult testing kits (2014-2023) ($MN)
Table 151 Middle East & Africa Critical Care Diagnostics Market Outlook, By Drugs-Of-Abuse testing kits (2014-2023) ($MN)
Table 152 Middle East & Africa Critical Care Diagnostics Market Outlook, By Coagulation monitoring kits (2014-2023) ($MN)
Table 153 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cholesterol test strips (2014-2023) ($MN)
Table 154 Middle East & Africa Critical Care Diagnostics Market Outlook, By Glucose monitoring kits (2014-2023) ($MN)
Table 155 Middle East & Africa Critical Care Diagnostics Market Outlook, By Pregnancy and fertility testing kits (2014-2023) ($MN)
Table 156 Middle East & Africa Critical Care Diagnostics Market Outlook, By Infectious Disease testing kits (2014-2023) ($MN)
Table 157 Middle East & Africa Critical Care Diagnostics Market Outlook, By Hematology testing kits (2014-2023) ($MN)
Table 158 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other critical care diagnostics testing kits (2014-2023) ($MN)
Table 159 Middle East & Africa Critical Care Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 160 Middle East & Africa Critical Care Diagnostics Market Outlook, By Hematology (2014-2023) ($MN)
Table 161 Middle East & Africa Critical Care Diagnostics Market Outlook, By Coagulation (2014-2023) ($MN)
Table 162 Middle East & Africa Critical Care Diagnostics Market Outlook, By Routine & Special Chemistry (2014-2023) ($MN)
Table 163 Middle East & Africa Critical Care Diagnostics Market Outlook, By Microbial & Infectious Test (2014-2023) ($MN)
Table 164 Middle East & Africa Critical Care Diagnostics Market Outlook, By Flow Cytometry (2014-2023) ($MN)
Table 165 Middle East & Africa Critical Care Diagnostics Market Outlook, By Immunoproteins (2014-2023) ($MN)
Table 166 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 167 Middle East & Africa Critical Care Diagnostics Market Outlook, By Prescription Mode (2014-2023) ($MN)
Table 168 Middle East & Africa Critical Care Diagnostics Market Outlook, By OTC Testing Kits (2014-2023) ($MN)
Table 169 Middle East & Africa Critical Care Diagnostics Market Outlook, By Prescription-Based Testing Kits (2014-2023) ($MN)
Table 170 Middle East & Africa Critical Care Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 171 Middle East & Africa Critical Care Diagnostics Market Outlook, By Ambulatory surgical centers (2014-2023) ($MN)
Table 172 Middle East & Africa Critical Care Diagnostics Market Outlook, By Home (2014-2023) ($MN)
Table 173 Middle East & Africa Critical Care Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 174 Middle East & Africa Critical Care Diagnostics Market Outlook, By Research Laboratories (2014-2023) ($MN)


More Publications